Steep Hill (XCNQ:STPH) Total Liabilities: C$0.15 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Steep Hill Total Liabilities?

Steep Hill XCNQ:STPH Total Liabilities is C$0.15 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Steep Hill's Total Liabilities for the quarter that ended in Dec. 2025 was C$0.15 Mil.

Steep Hill's quarterly Total Liabilities increased from Jun. 2025 (C$0.13 Mil) to Sep. 2025 (C$0.16 Mil) but then declined from Sep. 2025 (C$0.16 Mil) to Dec. 2025 (C$0.15 Mil).

Steep Hill's annual Total Liabilities declined from Dec. 2023 (C$1.11 Mil) to Dec. 2024 (C$0.26 Mil) and declined from Dec. 2024 (C$0.26 Mil) to Dec. 2025 (C$0.15 Mil).


Steep Hill Total Liabilities Historical Data

* Premium members only.

The historical data trend for Steep Hill's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steep Hill Total Liabilities Chart

Steep Hill Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 1.73 2.17 1.11 0.26 0.15

Steep Hill Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.16 0.13 0.16 0.15

Steep Hill Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Steep Hill's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1.984-1.837
=0.15

Steep Hill's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=1.984-1.837
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of C$0.15 Mil mean?
Steep Hill (XCNQ:STPH) has a Total Liabilities of C$0.15 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Steep Hill and its competitors.
Is Steep Hill's Total Liabilities too high?
Steep Hill's current Total Liabilities is C$0.15 Mil.
How does Steep Hill's Total Liabilities compare to ZTS and UTHR?
Steep Hill's Total Liabilities of C$0.15 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Steep Hill and its competitors. Steep Hill's current Total Liabilities is C$0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steep Hill stock overvalued right now?
Steep Hill (XCNQ:STPH) has a current Total Liabilities of C$0.15 Mil. The current Total Liabilities is C$0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Steep Hill (XCNQ:STPH), the current Total Liabilities is C$0.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Steep Hill Business Description

Address 120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1
Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the market with medicinal and wellness cannabidiol and other cannabinoid-based products.